FUNCTIONAL OBJECTIVES

FUNCTIONAL OBJECTIVES

1. Financial Perspective
a. Improve cost structure
b. Increase asset utilization
c. Enhance Customer value
d. Expand revenue opportunities

2. Customer Perspective (Customer Excellence)
a. Production of service attributes
b. Relation and Image development

3. Internal Perspective (Process Excellence)
a. Operation management processes
b. Public service management processes
c. Innovative Processes

4. Learning and Growth Perspective (Organizational Efficiency)
a. Human capital (Skills, training, knowledge)
b. Information capital (System, databases, networks)
c. Orgazinational capital (Skills/training, knowlege, teamwork)

FDA QUALITY POLICY

FDA QUALITY POLICY

Our highest commitment is to ensure
safety, efficacy and quality oh health products.

Towards this end,
we commit to maintain and establish science-based policies
based on national and international standards
as the basis for regulatory policies,
to continually improve and maintain
our competencies in relation
to our regulatory function,
and to deliver quality public
service with integrity and efficiency

FDA STRATEGIC OBJECTIVES

FDA STRATEGIC OBJECTIVES


RESTRUCTURING THE AGENCY'S FOUNDATION
(Year 2017-2019)

Establish an effective management information and operationg system
Reform the organizational structire and development resource
Strengthen enforment of FDA-Implemented laws, rules and regulations
Upgrade and improve facilities and infrastructure
Develop a sound and balance regulatory framework
Foster public confidence through effective communication

NEW STRATEGIES TO ACCELERATE GROWTH
(Year 2020-2021)

Cooperate and collaborate with other government agencies
Build a global presence and international accreditation
Increase digital enforcement activities
Develop mutual cooperation efforts and reciprocity with reputable National Regulatory Authorities and international activities
Increase FDA Academy Service Portfolio

Mandate

As a regulatory agency under the Department of Health, the Food and Drug Administration, created under Republic Act No. 3720, series of 1963, as amended by Executive Order 175, series of 1987, otherwise known as the “Food, Drugs and Devices, and Cosmetics Act”, and subsequently Republic Act No. 9711 otherwise known as “The Food and Drug Administration Act of 2009”, is mandated to ensure the safety, efficacy or quality of health products as defined by RA No. 97111, which include means food, drugs, cosmetics, devices, biologicals, vaccines, in-vitro diagnostic reagents, radiation-emitting devices or equipment, and household/urban hazardous substances, including pesticides and toys, or consumer products that may have an effect on health which require regulations as determined by the FDA.

Among others, the FDA is also mandated to enforce the provisions of the following laws:

  • RA 9502, or The Universally Accessible Cheaper and Quality Medicine Act of 2008, 
  • RA 6675, or  The Generics Act Of 1988, 
  • RA 5921, or The Pharmacy Law,
  • RA 9211, or The Tobacco Regulation Act of 2003
  • RA 7394, or The Consumer Act of the Philippines
  • RA 7581/10623, or The Price Act
  • RA 10611, or The Food Safety Act of 2013
  • RA  8172, or The ASIN Law,
  • RA 8203, or The Special Law on Counterfeit Drug
  • RA 8976, or The Food Fortification Law
  • RA 9165, or The Comprehensive Dangerous Drugs Act
  • RA 9257, or The Expanded Senior Citizens Act of 2003
  • PD No. 881, or The Household Hazardous Act
  • EO No. 51, or The Milk Code of the Philippines
  • RA 10354, or The Responsible Parenthood and Reproductive Health Bill of 2012
  • PD 856, or The Code of Sanitation of the Philippines

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter